Literature DB >> 34940888

Ertugliflozin, renoprotection and potential confounding by muscle wasting.

Dion Groothof1, Adrian Post2, Reinold O B Gans2, Stephan J L Bakker2.   

Abstract

Entities:  

Keywords:  Confounding; Diabetic nephropathy; Ertugliflozin; Muscle mass; Renal function

Mesh：

Substances：

Year:  2021        PMID： 34940888     DOI： 10.1007/s00125-021-05614-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 2.  GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

Authors:  Andrew S Levey; Lesley A Inker; Kunihiro Matsushita; Tom Greene; Kerry Willis; Edmund Lewis; Dick de Zeeuw; Alfred K Cheung; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-10-16       Impact factor: 8.860

3.  Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.

Authors:  David Z I Cherney; Bernard Zinman; Silvio E Inzucchi; Audrey Koitka-Weber; Michaela Mattheus; Maximilian von Eynatten; Christoph Wanner
Journal:  Lancet Diabetes Endocrinol       Date:  2017-06-27       Impact factor: 32.069

4.  Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.

Authors:  David Z I Cherney; Bruce A Perkins; Nima Soleymanlou; Maria Maione; Vesta Lai; Alana Lee; Nora M Fagan; Hans J Woerle; Odd Erik Johansen; Uli C Broedl; Maximilian von Eynatten
Journal:  Circulation       Date:  2013-12-13       Impact factor: 29.690

5.  Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

Authors:  Adrian Post; Michele F Eisenga; Stephan J L Bakker
Journal:  N Engl J Med       Date:  2019-09-12       Impact factor: 91.245

Review 6.  Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.

Authors:  Adriana Marton; Tatsuroh Kaneko; Jean-Paul Kovalik; Atsutaka Yasui; Akira Nishiyama; Kento Kitada; Jens Titze
Journal:  Nat Rev Nephrol       Date:  2020-10-01       Impact factor: 28.314

7.  The Glomerular Filtration Rate (GFR) at Dialysis Initiation and Mortality in Chronic Kidney Disease (CKD) in East Asian Populations: A Meta-analysis.

Authors:  Xin Lin; Xiang-Zhen Zeng; Jun Ai
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

8.  Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.

Authors:  David Z I Cherney; Bernard Charbonnel; Francesco Cosentino; Samuel Dagogo-Jack; Darren K McGuire; Richard Pratley; Weichung J Shih; Robert Frederich; Mario Maldonado; Annpey Pong; Christopher P Cannon
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

9.  Muscle mass versus body mass index as predictor of adverse outcome.

Authors:  Dion Groothof; Adrian Post; Harmke A Polinder-Bos; Bouke P C Hazenberg; Reinold O B Gans; Stephan J L Bakker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-02-14       Impact factor: 12.910

10.  When and how can endpoints be changed after initiation of a randomized clinical trial?

Authors:  Scott Evans
Journal:  PLoS Clin Trials       Date:  2007-04-13
  10 in total
  2 in total

1.  Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].

Authors:  David Z I Cherney; Bernard Charbonnel; Francesco Cosentino; Samuel Dagogo-Jack; Darren K McGuire; Richard Pratley; Weichung J Shih; Robert Frederich; Mario Maldonado; Annpey Pong; Christopher P Cannon
Journal:  Diabetologia       Date:  2022-03-03       Impact factor: 10.122

2.  Muscle mass and estimates of renal function: a longitudinal cohort study.

Authors:  Dion Groothof; Adrian Post; Harmke A Polinder-Bos; Nicole S Erler; Jose L Flores-Guerrero; Jenny E Kootstra-Ros; Robert A Pol; Martin H de Borst; Ron T Gansevoort; Reinold O B Gans; Daan Kremer; Lyanne M Kieneker; Arjola Bano; Taulant Muka; Oscar H Franco; Stephan J L Bakker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-05-21       Impact factor: 12.063
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.